Lung Cancer

Medicaid may not offer as much benefit to those with small-cell lung cancer, a rapidly-spreading disease that requires as fast a response as possible, according to a recent analysis. 

In this episode of the "CURE Talks Cancer" podcast, the keynote speaker for the CURE Patient-Focused Sessions at the New York Lung Cancers Symposium shares how a pain under her arm led to her diagnosis in less than 48 hours.
 

First-line Tagrisso significantly extended overall survival compared with first generation EGFR-TKIs in patients with Ex19del/L858R EGFR mutated advanced non–small cell lung cancer, according to results from the phase 3 FLAURA study.

First-line treatment with Opdivo plus low-dose Yervoy improved survival among patients with advanced NSCLC compared to chemotherapy, according to results from the CheckMate-227 trial.
 

A recent survey found that lung cancer stigma can be a barrier to treatment; however, on the plus side, the percentage of people who associate the disease with smoking has dropped in recent years.

After a 10-year battle with cancer, the beloved actress, wife, mother and advocate passed away at 80.

Traveling helped me remove myself from the storyline of cancer and reconnect with the world around me.

Here’s a sneak peek at what’s inside our Summer 2019 issue.

Hossein Borghaei, Fox Chase Cancer Center - a physician in the field of cancer care - discusses his experiences treating patients with non-small cell lung cancer and why recent data is now available and could have a positive impact on the treatment landscape. 

The American Lung Association’s chief medical officer discusses e-cigarette use and answers common questions surrounding this increasing epidemic.